Solid Biosciences Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue00000000
Cost of Goods Sold395K00386K407K000
Gross Profit-395K00-386K-407K000
R&D Expenses46.1M38.1M38.9M32.4M30.9M30.8M27.3M19.5M
Operating Expenses56.9M49.4M48.1M41.3M39.6M39.9M35.2M27.8M
Operating Income-57.3M-49.4M-48.1M-41.7M-40.1M-39.9M-35.2M-27.8M
Other Income / Gains571K-384K2.3M2.2M770K-2.7M2.5M2.7M
Net Income-56.7M-49.8M-45.8M-39.5M-39.3M-42.6M-32.7M-25.1M
EPS (Diluted)-0.52-0.53-0.48-0.42-0.59-0.80-0.79-0.61
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio00000000
General And Administrative Expenses11.2M11.3M9.2M9.3M9.1M9.1M7.9M8.3M
Selling And Marketing Expenses00000000
Selling General And Administrative Expenses11.2M11.3M9.2M9.3M9.1M9.1M7.9M8.3M
Other Expenses-395K00-386K-407K000
Cost And Expenses57.3M49.4M48.1M41.7M40.1M39.9M35.2M27.8M
Interest Income2.1M2.0M2.6M3.0M2.3M1.9M2.3M2.6M
Interest Expense00060K68K75K82K88K
Depreciation And Amortization395K467K376K386K407K488K405K1.2M
Ebitda-56.3M-49.3M-45.4M-39.0M-38.8M-42.0M-32.2M-23.7M
Ebitdaratio00000000
Operating Income Ratio00000000
Income Before Tax-56.7M-49.8M-45.8M-39.5M-39.3M-42.6M-32.7M-25.1M
Income Before Tax Ratio00000000
Income Tax Expense00000000
Net Income Ratio00000000
Epsdiluted-0.52-0.53-0.48-0.42-0.59-0.80-0.79-0.61
Weighted Average Shs Out109.8M94.7M94.4M94.1M66.3M53.6M41.4M40.9M
Weighted Average Shs Out Dil109.8M94.7M94.4M94.1M66.3M53.6M41.4M40.9M